Novel insights into the pathogenesis of molecular subtypes of diffuse large B-cell lymphoma and their clinical implications

被引：14

作者：

Frontzek, Fabian ^{[1
]}

Lenz, Georg ^{[1
]}

机构：

[1] Univ Hosp Munster, Dept Med Hematol Oncol & Pneumol A, D-48149 Munster, Germany

来源：

EXPERT REVIEW OF CLINICAL PHARMACOLOGY | 2019年 / 12卷 / 11期

关键词：

ABC; GCB; DLBCL; C1-C5; clusters; NF-kappa B; targeted therapy; NF-KAPPA-B; RITUXIMAB PLUS CYCLOPHOSPHAMIDE; NON-HODGKIN-LYMPHOMA; PHASE-III TRIAL; IN-VITRO; MYC; GENE; INHIBITION; EXPRESSION; SURVIVAL;

D O I：

10.1080/17512433.2019.1683447

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Introduction: Diffuse large B-cell lymphoma (DLBCL) represents a heterogeneous diagnostic category consisting of different molecular subtypes relying in their biology on distinct signaling pathways. Areas covered: This article provides an overview of the molecular understanding in DLBCL and highlights potential clinical implications reviewing relevant publications and clinical trials from PubMed and clinicaltrials.gov until August 2019. Expert opinion: Based on gene expression profiling, DLBCL can be divided in two broad subtypes, the activated B-cell-like (ABC) and germinal centre derived (GCB) DLBCL. Recent comprehensive genomic analyses revealed reproducible molecular clusters within the ABC/GCB classification and suggest a more profound molecular characterization to stratify patients within clinical trials. During the last couple of years, a multitude of novel targeted therapies has been developed, but so far without improving our current therapeutic standard of immunochemotherapy. Next to the limitation of toxic side effects and a more precise selection of patients, one of the greatest challenges will be to provide molecular characterization in a more time efficient way to enable a specific and individual treatment strategy.

引用

页码：1059 / 1067

页数：9

共 85 条

[31] BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma [J].

Iqbal, J ;

Sanger, WG ;

Horsman, DE ;

Rosenwald, A ;

Pickering, DL ;

Dave, B ;

Dave, S ;

Xiao, L ;

Cao, KJ ;

Zhu, QM ;

Sherman, S ;

Hans, CP ;

Weisenburger, DD ;

Greiner, TC ;

Gascoyne, RD ;

Ott, G ;

Müller-Hermelink, HK ;

Delabie, J ;

Braziel, RM ;

Jaffe, ES ;

Campo, E ;

Lynch, JC ;

Connors, JM ;

Vose, JM ;

Armitage, JO ;

Grogan, TM ;

Staudt, LM ;

Chan, WC .

AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (01) :159-166

[32] Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone [J].

Johnson, Nathalie A. ;

Slack, Graham W. ;

Savage, Kerry J. ;

Connors, Joseph M. ;

Ben-Neriah, Susana ;

Rogic, Sanja ;

Scott, David W. ;

Tan, King L. ;

Steidl, Christian ;

Sehn, Laurie H. ;

Chan, Wing C. ;

Iqbal, Javeed ;

Meyer, Paul N. ;

Lenz, Georg ;

Wright, George ;

Rimsza, Lisa M. ;

Valentino, Carlo ;

Brunhoeber, Patrick ;

Grogan, Thomas M. ;

Braziel, Rita M. ;

Cook, James R. ;

Tubbs, Raymond R. ;

Weisenburger, Dennis D. ;

Campo, Elias ;

Rosenwald, Andreas ;

Ott, German ;

Delabie, Jan ;

Holcroft, Christina ;

Jaffe, Elaine S. ;

Staudt, Louis M. ;

Gascoyne, Randy D. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (28) :3452-3459

[33] Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival [J].

Johnson, Nathalie A. ;

Savage, Kerry J. ;

Ludkovski, Olga ;

Ben-Neriah, Susana ;

Woods, Ryan ;

Steidl, Christian ;

Dyer, Martin J. S. ;

Siebert, Reiner ;

Kuruvilla, John ;

Klasa, Richard ;

Connors, Joseph M. ;

Gascoyne, Randy D. ;

Horsman, Douglas E. .

BLOOD, 2009, 114 (11) :2273-2279

[34]

JOHNSON SA, 1995, J IMMUNOL, V155, P4596

[35] Aberrant NF-κB signaling in lymphoma:: mechanisms, consequences, and therapeutic implications [J].

Jost, Philipp J. ;

Ruland, Juergen .

BLOOD, 2007, 109 (07) :2700-2707

[36]

Kahl B, 2010, BLOOD, V116, P741

[37] Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma [J].

Lam, Lloyd T. ;

Wright, George ;

Davis, R. Eric ;

Lenz, Georg ;

Farinha, Pedro ;

Dang, Lenny ;

Chan, John W. ;

Rosenwald, Andreas ;

Gascoyne, Randy D. ;

Staudt, Louis M. .

BLOOD, 2008, 111 (07) :3701-3713

[38]

Lam LT, 2005, CLIN CANCER RES, V11, P28

[39] Stromal Gene Signatures in Large-B-Cell Lymphomas [J].

Lenz, G. ;

Wright, G. ;

Dave, S. S. ;

Xiao, W. ;

Powell, J. ;

Zhao, H. ;

Xu, W. ;

Tan, B. ;

Goldschmidt, N. ;

Iqbal, J. ;

Vose, J. ;

Bast, M. ;

Fu, K. ;

Weisenburger, D. D. ;

Greiner, T. C. ;

Armitage, J. O. ;

Kyle, A. ;

May, L. ;

Gascoyne, R. D. ;

Connors, J. M. ;

Troen, G. ;

Holte, H. ;

Kvaloy, S. ;

Dierickx, D. ;

Verhoef, G. ;

Delabie, J. ;

Smeland, E. B. ;

Jares, P. ;

Martinez, A. ;

Lopez-Guillermo, A. ;

Montserrat, E. ;

Campo, E. ;

Braziel, R. M. ;

Miller, T. P. ;

Rimsza, L. M. ;

Cook, J. R. ;

Pohlman, B. ;

Sweetenham, J. ;

Tubbs, R. R. ;

Fisher, R. I. ;

Hartmann, E. ;

Rosenwald, A. ;

Ott, G. ;

Muller-Hermelink, H. -K ;

Wrench, D. ;

Lister, T. A. ;

Jaffe, E. S. ;

Wilson, W. H. ;

Chan, W. C. ;

Staudt, L. M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (22) :2313-2323

[40] Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways [J].

Lenz, Georg ;

Wright, George W. ;

Emre, N. C. Tolga ;

Kohlhammer, Holger ;

Dave, Sandeep S. ;

Davis, R. Eric ;

Carty, Shannon ;

Lam, Lloyd T. ;

Shaffer, A. L. ;

Xiao, Wenming ;

Powell, John ;

Rosenwald, Andreas ;

Ott, German ;

Muller-Hermelink, Hans Konrad ;

Gascoyne, Randy D. ;

Connors, Joseph M. ;

Campo, Elias ;

Jaffe, Elaine S. ;

Delabie, Jan ;

Smeland, Erlend B. ;

Rimsza, Lisa M. ;

Fisher, Richard I. ;

Weisenburger, Dennis D. ;

Chan, Wing C. ;

Staudt, Louis M. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (36) :13520-13525

← 1 2 3 4 5 6 7 8 9 →